Status:
RECRUITING
Role of Pancreatic Exocrine Secretion in Weight Gain After Pancreas Transplantation
Lead Sponsor:
Rush University Medical Center
Conditions:
Exocrine Pancreatic Insufficiency
Weight Gain
Eligibility:
All Genders
18-80 years
Brief Summary
Pancreas transplantation is currently the most reliable method for glycemic control in insulin dependent diabetic patients. Outcomes of pancreas transplantation have improved significantly over the ye...
Detailed Description
This is the second of a two-part study. The first part, a pilot study, assessed the FEC level after pancreas transplant to determine if FEC is high compared to that of the general population and see i...
Eligibility Criteria
Inclusion
- Recipients of pancreas transplant with or without other organs
- Age 18 - 80 yrs
Exclusion
- Unwillingness to consent or participate in the study
Key Trial Info
Start Date :
August 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04690738
Start Date
August 17 2020
End Date
December 31 2030
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612